Showing results (2091-2100 of 2,292) with videos related to

Sort By:
Pageof 230
Biorxiv : the Preprint Server for Biology|October 17, 2024
Activation of Heme Metabolism Promotes Tissue Health After Intraarticular Injury or Surgical ExposureSuryamin Liman, Piedad C Gomez-Contreras, Madeline R Hines, et al.
The Journal of Biological Chemistry|November 22, 2023
Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formationZsuzsa Radvanyi, Eun Jin Yoo, Palanivel Kandasamy, et al.
Clinical Kidney Journal|May 18, 2026
Long-term citrate treatment in high-risk kidney stone formers is not associated with metabolic adverse effectsAlexander Ritter, Lea Bührer, Daniel G Fuster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch studyM Paulussen, S Ahrens, M Lehnert, et al.
Lancet (London, England)|July 4, 1998
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Survival in hereditary breast cancer associated with germline mutations of BRCA2L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Clinical Pharmacology and Therapeutics|March 13, 2009
Pharmacokinetics of raltegravir in individuals with UGT1A1 polymorphismsL A Wenning, A S Petry, J T Kost, et al.
The Journal of Urology|September 28, 2017
Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM RegistryAkachimere C Uzosike, Hiten D Patel, Ridwan Alam, et al.
The Journal of Biological Chemistry|December 31, 2003
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivityUtpal B Pajvani, Meredith Hawkins, Terry P Combs, et al.
Cancer Chemotherapy and Pharmacology|February 6, 2013
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trialJ L Welsh, B A Wagner, T J van't Erve, et al.
Pageof 230